Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-0867-2016

Drug recall · June 1, 2016

OCTREOTIDE ACETATE INJECTION recall

Why: Failed Impuities/Degradation Specifications

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

OCTREOTIDE ACETATE INJECTION, 50 mcg (base)/mL (0.05 mg/mL), 1 mL Single Dose Vial, Rx only, Manufactured by Fresenius Kabi USA, LLC, Schaumburg, IL 60173, NDC 63323-365-04

Lots / codes

Lot # 6108831; Exp. 07/16

Quantity
40,280 vials
Company
Fresenius Kabi USA, LLC, Lake Zurich, IL
Distribution
Nationwide and Puerto Rico.
Initiated
May 4, 2016 · Voluntary: Firm initiated
Classified
May 24, 2016
Reported
June 1, 2016
Ended
January 23, 2017
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Octreotide

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.